老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Galmed Pharmaceuticals

4.63
0.0000
成交量：- -
成交额：- -
市值：482.26万
市盈率：-0.33
高：4.63
开：4.63
低：4.63
收：4.63
52周最高：12.80
52周最低：3.29
股本：104.16万
流通股本：100.99万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-14.1059
每股收益(LYR):-19.1292
净资产收益率：-68.21%
总资产收益率：-30.19%
市净率：0.38
市盈率(LYR):-0.24

数据加载中...

总览公司新闻资讯公告
2021/01/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/06

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/12

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/12

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多